contadores web
Skip to main navigation menu Skip to main content Skip to site footer
##common.pageHeaderLogo.altText##

Scientific and technological research article

Vol. 22 No. Suppl 1 (2020)

Analysis of COVID-19 mortality in Colombia: Measures of disease occurrence

DOI
https://doi.org/10.22267/rus.202203.202
Submitted
November 12, 2020
Published
2020-12-10

Abstract

Introduction: The risk of dying from COVID-19 varies considerably between regions and countries and it is assessed through fatality indices and mortality rates. Objective: To describe the measures of mortality occurrence due to COVID-19 in Colombia. Materials and methods: Cases of coronavirus infections reported to the National Institute of Health of Colombia during the months of March and October 2020 were included. The fatality indices and mortality rates are presented as proportions and million/people ratios, respectively. Results: The fatality index for confirmed COVID-19 cases varied between regions, changed as the pandemic progressed and was initially high because diagnostic tests were conducted on severe symptomatic cases. Also, this index was underestimated due to delays in notification. In Bogota, Cali, Medellin and Cartagena, the impact of the pandemic was minor, with gradual increases and decreases in the mortality rates. On the contrary, in Barranquilla, Bucaramanga and Pasto, the curves showed sudden increments and declines, which were related to more deaths registered during the peak of the pandemic. Conclusions: The fatality indices and mortality rates of COVID-19 facilitate the monitoring of the pandemic, but they can be distorted by posthumous diagnosis of SARS-CoV-2 infection and delays in notification.

References

  1. Perone G. The determinants of COVID-19 case fatality rate (CFR) in the Italian regions and provinces: An analysis of environmental, demographic, and healthcare factors. Sci Total Environ [Internet]. 2020;755:142523. Available from: https://doi.org/10.1016/j.scitotenv.2020.142523
  2. WHO. Estimating mortality from COVID-19: Scientific brief [Internet]. 2020. Available from: https://www.who.int/publications/i/item/WHO-2019-nCoV-Sci-Brief-Mortality-2020.1
  3. WHO. Public health criteria to adjust public health and social measures in the context of COVID-19. [Internet]. Who. 2020. Available from: https://apps.who.int/iris/bitstream/handle/10665/332073/WHO-2019-nCoVAdjusting_PH_measures-Criteria-2020.1-eng.pdf?sequence=1&isAllowed=y
  4. Mantha S. Ratio, rate, or risk? Lancet Infect Dis [Internet]. 2020;3099(20):30439. Available from: http://dx.doi.org/10.1016/S1473-3099(20)30439-4
  5. Warner P. Rate and rate ratio. J Fam Plan Reprod Heal Care. 2009;35(2):111–3.
  6. Grillo Ardila EK, Bravo Ocaña LE, Guerrero R, Santaella-Tenorio J. Mathematical models and the coronavirus, COVID-19. Colomb Med [Internet]. 2020:1–9. Available from: https://colombiamedica.univalle.edu.co/index.php/comedica/article/view/4277/4760
  7. Minsalud. Así muta el SARS-CoV-2/covid-19 sin aumentar su letalidad [Internet]. 2020. p. 1–2. Available from: https://www.minsalud.gov.co/Paginas/Asi-muta-el-SARS-CoV-2-covid-19-sin-aumentar-su-letalidad.aspx
  8. Vankadari N. Overwhelming mutations or SNPs of SARS-CoV-2: A point of caution. Gene [Internet]. 2020;752(May). Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7239005/pdf/main.pdf
  9. Meyerowitz-Katz G, Merone L. A systematic review and meta-analysis of published research data on COVID-19 infection-fatality rates. Int J Infect Dis [Internet]. 2020;S12019712(September):1–42. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7524446/pdf/main.pdf
  10. Russell TW, Hellewell J, Jarvis CI, Zandvoort K Van, Abbott S, Ratnayake R, et al. Estimating the infection and case fatality ratio for coronavirus disease (COVID-19) using age-adjusted data from the outbreak on the Diamond Princess cruise ship, February 2020. Eurosurveillance. 2020;25(12):1–5.
  11. Vivo EN, Coronavirus M. MinSalud cambia la forma de contar las muertes por coronavirus: ¿cómo es el nuevo reporte? [Internet]. 2020. p. 1–5. Available from: https://colombia.as.com/colombia/2020/07/31/actualidad/1596146425_535167.html
  12. DANE. anexo-proyecciones-poblacion-Nacional2018_2070 [Internet]. 2018. Available from: https://www.dane.gov.co/index.php/estadisticas-por-tema/demografia-y-poblacion/proyecciones-de-poblacion
  13. StataCorp. 2015. Stata Statistical Software: Release 14. College Station, TX: StataCorp LP.
  14. Condit R. Infec on Fatality Rate – A Critical Missing Piece for Managing Covid-19 [Internet]. 2020. p. 1–23. Available from: https://www.virology.ws/2020/04/05/infection-fatality-rate-a-critical-missing-piece-for-managing-covid-19/
  15. Ward S, Lindsley A, Courter J, Assa A. Clinical testing for COVID-19. J Allergy Clin Inmunol [Internet]. 2020;146–1(July):23–34. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7237919/pdf/main.pdf
  16. Müller O, Neuhann F, Razum O. Epidemiology and control measures in COVID-19. Dtsch Med Wochenschr [Internet]. 2020;145(10):670–4. Available from: https://dx.doi.org/10.1055/a-1162-1987
  17. Ministerio de Salud y Protección Social. GUIA PARA EL REPORTE Y VERIFICACION DE LAS DEFUNCIONES EN SEGCOVID-19 [Internet]. 2020. p. 1–31. Available from: https://www.minsalud.gov.co/Ministerio/Institucional/Procesos y procedimientos/PSPG04.pdf
  18. MinSalud. LINEAMIENTOS PARA EL USO DE PRUEBAS DIAGNÓSTICAS DE LABORATORIO DURANTE LA PANDEMIA DEL SARS-COV-2 (COVID-19) EN COLOMBIA Ministerio de Salud y Protección Social Bogotá, abril de 2020. Minist salud del Ecuador [Internet]. 2020;2(1):1–34. Available from: https://www.minsalud.gov.co/Ministerio/Institucional/Procesos y procedimientos/GIPS21.pdf

Downloads

Download data is not yet available.

Most read articles by the same author(s)